Balaji Amines Ltd Share Price (BALAMINES)

Balaji Amines' ROCE Decreases to 15% - 05 Apr, 2024

Balaji Amines' returns on capital employed (ROCE) have decreased from 26% to 15% in the last five years due to a drop in revenue while employing more capital. The decrease in current liabilities could reduce some risk but also make the business less efficient at generating ROCE.

Balaji Amines Stock Surges on Positive Earnings Outlook - 04 Apr, 2024

Shares of Balaji Amines have surged, with analysts predicting a positive turnaround in Q1 earnings. The rally began post-March 28.

Balaji Amines Ltd: Leading Manufacturer of Methylamines and Ethylamines - 27 Mar, 2024

Balaji Amines Ltd is a leading manufacturer of Methylamines, Ethylamines, and derivatives with six manufacturing units spread across ~270 acres. In 9M FY24, earnings per share stood at Rs 42.2. The stock trades at 37 times annualised 9M FY24 EPS.

Balaji Amines Q3 FY24 Revenue Falls 34.6% - 21 Mar, 2024

Balaji Amines' revenue fell by 34.6% in Q3-FY24 due to destocking of inventory by Chinese companies and headwinds faced by the end-user industry, resulting in lower realisation in key products. However, volumes are expected to revive in the next few quarters as the pharma & API industry appears to have turned a corner. The stock currently trades at 35.1x FY24e EPS and 23.3x FY25 EPS. Analysts retain their buy rating on the stock with a target price of ₹2,653 based on 30x FY25 EPS over a period of 9-12 months.

Balaji Amines Q3 Revenue Falls 34.6% - 20 Mar, 2024

Balaji Amines' Q3FY24 revenue fell by 34.6% to Rs 383.36 crore, but volumes are expected to revive in the next few quarters as pharma and API industry recovers. CD Equisearch has retained its buy rating on the stock with a target price of Rs 2653 based on 30x FY25e EPS over 9-12 months.

India Ratings Affirms Balaji Amines' Long-Term Issuer Rating at IND AA - 14 Mar, 2024

Balaji Amines has received an affirmed Long-Term Issuer Rating of IND AA from India Ratings and Research Private Limited, with a Stable Outlook. The Fund-based working capital facilities rating was also affirmed at IND AA/Stable/IND A1+, while the Non-Fund-based working capital facilities rating was affirmed at IND A1+.